How The EU, US & Brazil Are Shaping Decentralized Manufacturing For ATMPs

Regulators in Europe and the US have demonstrated a commitment to providing guidance that will make decentralized and point-of-care manufacturing a reality, the CSO of GermFree, a company that provides mobile and modular cleanrooms for manufacturing advanced therapies, tells the Pink Sheet.

GermFree Mobile Cleanroom
A look inside one of GermFree's modular cleanrooms • Source: GermFree

Patients in need of advanced therapy medicinal products (ATMPs) face many access challenges, even in countries where the reimbursement of these innovative medicines is covered by national health insurance funding.

One major hurdle for both patients and pharmaceutical companies in the ATMP space is manufacturing, given that making autologous products...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from United States

More from Interviews